<DOC>
	<DOCNO>NCT02400658</DOCNO>
	<brief_summary>The purpose study evaluate investigational way provide radiation therapy treat early-stage breast cancer time surgery .</brief_summary>
	<brief_title>Efficacy IORT With CT-Guided HDR Brachytherapy Treatment Breast Cancer</brief_title>
	<detailed_description>This prospective single-arm phase II study design study efficacy high dose rate ( HDR ) brachytherapy CT-imaging , single-fraction intraoperative radiation therapy ( IORT ) . The study accrue patient early-stage breast cancer treat breast-conserving surgery ( BCS ) . The main clinical eligibility criterion base suitability accelerate partial breast irradiation . Patients may eligible prior receive BCS within 30 day receive BCS . Eligible patient undergo BCS receive surgery accord standard clinical practice Brachytherapy Suite Emily Couric Clinical Cancer Center . Patients already undergone BCS must meet eligibility criterion able treated IORT within 30 day breast surgery . Eligible subject undergo lumpectomy re-excision lumpectomy accord standard clinical practice . Immediately follow lumpectomy , breast HDR brachytherapy applicator place CT image perform treatment planning . After HDR brachytherapy deliver , applicator remove , breast surgeon complete skin closure . Although ultimate goal study determine 5-year ipsilateral breast tumor recurrence ( IBTR ) , effort make follow patient death .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>1 . Patient elect breast conserving surgery whole breast irradiation treatment earlystage breast cancer . 2 . Tumor size must less equal 3 cm . 3 . Patient 45 year age old . 1 . Male patient . 2 . Pregnant patient . 3 . Breast cancer involve skin chest wall . 4 . History ipsilateral breast cancer . 5 . Multicentric breast cancer ipsilateral breast . 6 . Known BRCA gene mutation . 7 . Patient nodal disease . 8 . Patient undergoing initial medical treatment ( hormone chemotherapy ) reduce tumor size . 9 . Patient breast implant ( include patient implant AFTER intraoperative radiotherapy ) .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>early-stage</keyword>
	<keyword>IORT</keyword>
	<keyword>brachytherapy</keyword>
</DOC>